Total Payments
$738.55
2024 Payments
$123.48
Companies
9
Transactions
43
Medicare Patients
996
Medicare Billing
$126,427
Payment Breakdown by Category
Food & Beverage$738.55 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $738.55 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $248.47 | 2 | $0 (2024) |
| Novo Nordisk Inc | $246.05 | 23 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $95.54 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $38.45 | 3 | $0 (2021) |
| Amarin Pharma Inc. | $33.15 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.68 | 2 | $0 (2018) |
| SANOFI PASTEUR INC. | $24.94 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $13.47 | 1 | $0 (2017) |
| PFIZER INC. | $12.80 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.48 | 1 | Alexion Pharmaceuticals, Inc. ($123.48) |
| 2023 | $124.99 | 1 | Alexion Pharmaceuticals, Inc. ($124.99) |
| 2021 | $11.81 | 1 | AstraZeneca Pharmaceuticals LP ($11.81) |
| 2019 | $187.06 | 20 | Novo Nordisk Inc ($124.58) |
| 2018 | $166.67 | 12 | Novo Nordisk Inc ($54.82) |
| 2017 | $124.54 | 8 | Novo Nordisk Inc ($66.65) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: Rare Disease | ||||||
| 04/13/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Rare Disease | ||||||
| 03/04/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: Diabetes | ||||||
| 11/23/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Diabetes | ||||||
| 11/23/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Diabetes | ||||||
| 11/23/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Diabetes | ||||||
| 11/14/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/31/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: Diabetes | ||||||
| 10/30/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: Diabetes | ||||||
| 09/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Diabetes | ||||||
| 09/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: Diabetes | ||||||
| 08/22/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 07/24/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2019 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 06/04/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Diabetes | ||||||
| 05/30/2019 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT (Drug), FLUBLOK QUADRIVALENT, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: VACCINES | ||||||
| 05/08/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 03/05/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Diabetes | ||||||
| 02/28/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Cardiovascular | ||||||
| 02/07/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Diabetes | ||||||
| 01/15/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Diabetes | ||||||
| 11/28/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 11/01/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 223 | 405 | $102,187 | $34,084 |
| 2022 | 4 | 165 | 214 | $67,760 | $23,295 |
| 2021 | 5 | 193 | 273 | $50,104 | $24,303 |
| 2020 | 11 | 415 | 600 | $88,159 | $44,746 |
Total Patients
996
Total Services
1,492
Medicare Billing
$126,427
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 252 | $76,242 | $25,337 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 34 | $14,310 | $4,349 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 36 | $7,590 | $2,437 | 32.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $2,240 | $1,151 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $1,100 | $657.40 | 59.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 46 | 47 | $705.00 | $153.00 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 84 | $37,800 | $12,701 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 74 | $24,050 | $7,838 | 32.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 26 | 26 | $3,510 | $1,782 | 50.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $2,400 | $974.70 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 192 | $33,600 | $16,369 | 48.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 30 | 34 | $7,990 | $4,221 | 52.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $2,019 | $1,620 | 80.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 21 | $2,520 | $1,282 | 50.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,975 | $810.07 | 20.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 135 | 265 | $46,375 | $21,054 | 45.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 41 | 56 | $13,160 | $6,623 | 50.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 76 | $9,120 | $3,907 | 42.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 39 | 45 | $6,350 | $3,799 | 59.8% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 12 | 12 | $3,000 | $2,722 | 90.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 27 | 31 | $2,755 | $1,850 | 67.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 30 | 31 | $2,170 | $1,823 | 84.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 14 | 14 | $2,569 | $1,777 | 69.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 39 | 40 | $1,600 | $715.28 | 44.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 16 | 16 | $640.00 | $292.86 | 45.8% |
About Dr. Suzanne Shenk, D.O
Dr. Suzanne Shenk, D.O is a Internal Medicine healthcare provider based in Stratford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447352364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suzanne Shenk, D.O has received a total of $738.55 in payments from pharmaceutical and medical device companies, with $123.48 received in 2024. These payments were reported across 43 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($738.55).
As a Medicare-enrolled provider, Shenk has provided services to 996 Medicare beneficiaries, totaling 1,492 services with total Medicare billing of $126,427. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Stratford, NJ
- Active Since 09/01/2006
- Last Updated 06/14/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1447352364
Products in Payments
- STRENSIQ (Biological) $124.99
- ULTOMIRIS (Biological) $123.48
- Victoza (Drug) $99.89
- Livalo (Drug) $95.54
- Ozempic (Drug) $83.67
- Tresiba (Drug) $47.72
- FARXIGA (Drug) $38.45
- Vascepa (Drug) $33.15
- Xultophy 100/3.6 (Drug) $14.77
- ANORO (Drug) $13.47
- MENACTRA (Drug) $13.06
- PREVNAR - 13 (Biological) $12.80
- FLUZONE QUADRIVALENT (Drug) $11.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Stratford
Dr. Edward Carreras, M.d, M.D
Internal Medicine — Payments: $27,269
Internal Medicine $27,269
Dr. Lucia Chou, M.d, M.D
Internal Medicine — Payments: $21,643
Internal Medicine $21,643
Panayotes Yannopoulos, Md, MD
Internal Medicine — Payments: $17,274
Internal Medicine $17,274
Dr. Bobby Malik, Md, MD
Internal Medicine — Payments: $11,929
Internal Medicine $11,929
Leonid Karkanitsa, Md, MD
Internal Medicine — Payments: $8,720
Internal Medicine $8,720
Dr. Magdala Chery, D.o, D.O
Internal Medicine — Payments: $6,644
Internal Medicine $6,644